The identification of a gain-of-function mutation in the TASK-4 channel (KCNK17) in a patient with severe conduction disorder and IVF highlights KCNK17 as a novel arrhythmia gene and supports a second-hit hypothesis in severe cases.
No takes yet. Share an insight, caveat, or question.
Does not yet alter clinical management of conduction disease; leaves open KCNK17 as a novel arrhythmia gene pending human validation.
Friedrich et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: